Endovascular or surgical popliteal aneurysms exclusion – both with good results but for different patients.

Original title: A Multicentric Experience with Open Surgical Repair and Endovascular Exclusion of Popliteal Artery Aneurysms. Reference: R. Pulli et al. European Journal of Vascular and Endovascular Surgery, Volume 45, Issue 4, Pages 357-363.

 

Complications of a popliteal aneurysm may cause rupture, distal embolization or thrombosis with a risk of any of them affecting the lower limb. That’s why elective treatment of asymptomatic aneurysms larger than 20 mm is recommended. The surgery has good results although recently the possibility of endovascular stent graft exclusion has also emerged.

This retrospective multicenter registry analyzed the results of 312 popliteal aneurysms (178 treated with surgery and 134 endovascular) over a period of ten years. 

The choice of strategy was at the discretion of the treating physicians, although there were clear differences especially in the clinical presentation. The 71% treated as endovascular were asymptomatic. The opposite was true for those who received surgical treatment where 64.5% were symptomatic of claudication or acute ischemia. In the endovascular group stent grafts were used, (Hemobahn or Viabahn, WL Gore & Associates Inc, Flagstaff, AZ, USA), implanted most frequently by ipsilateral access. In the surgical group thrombosis was observed in six patients (3.3%), three of which could be resolved but the other three required major amputation. After follow-up at 12, 24 and 48-months, primary patency of this group was 78.8%, 77.1% and 63.4% respectively.  In the endovascular group seven patients developed thrombosis,  (9.7%), all could be resolved except for one patient who required major amputation. Primary patency of endovascular treatment at 12, 24 and 48 months was 79.1%, 76.9% and 73.4% respectively.

Conclusion:

In this study, which has the highest record of popliteal aneurysms, surgical or endovascular treatment was used in different patients, preferring the surgical strategy for acute presentation and endovascular for asymptomatic. Both strategies showed good results in the short and long term. 

Editorial comment:

You cannot directly compare the results of both strategies and the clinical presentation was often opposite. For the surgical group the results were better if used instead of autogenous vein graft. No randomized studies are currently available on this topic.

SOLACI.ORG

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...